99 related articles for article (PubMed ID: 9218312)
1. Tumor blood flow and the cytotoxic effects of estramustine and its constituents in a rat glioma model.
Johansson M; Bergenheim AT; Henriksson R; Koskinen LO; Vallbo C; Widmark A
Neurosurgery; 1997 Jul; 41(1):237-43; discussion 243-4. PubMed ID: 9218312
[TBL] [Abstract][Full Text] [Related]
2. Distribution of estramustine in the BT4C rat glioma model.
Johansson M; Bergenheim AT; D'Argy R; Edman K; Gunnarsson PO; Widmark A; Henriksson R
Cancer Chemother Pharmacol; 1998; 41(4):317-25. PubMed ID: 9488601
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic tumor cell death induced by estramustine in patients with malignant glioma.
Vallbo C; Bergenheim AT; Bergström P; Gunnarsson PO; Henriksson R
Clin Cancer Res; 1998 Jan; 4(1):87-91. PubMed ID: 9516956
[TBL] [Abstract][Full Text] [Related]
4. The antimicrotubule drug estramustine but not irradiation induces apoptosis in malignant glioma involving AKT and caspase pathways.
Vallbo C; Bergenheim T; Hedman H; Henriksson R
J Neurooncol; 2002 Jan; 56(2):143-8. PubMed ID: 11995815
[TBL] [Abstract][Full Text] [Related]
5. DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain--suggesting an apoptotic cell death.
Vallbo C; Bergenheim T; Bergh A; Grankvist K; Henriksson R
Br J Cancer; 1995 Apr; 71(4):717-20. PubMed ID: 7710934
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitizing effect of estramustine in malignant glioma in vitro and in vivo.
Bergenheim AT; Zackrisson B; Elfverson J; Roos G; Henriksson R
J Neurooncol; 1995; 23(3):191-200. PubMed ID: 7673981
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effect and uptake of estramustine in a rat glioma model.
Bergenheim A; Elfverson J; Gunnarsson P; Edman K; Hartman M; Henriksson R
Int J Oncol; 1994 Aug; 5(2):293-9. PubMed ID: 21559588
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced apoptosis by anti-microtubule agent, estramustine phosphate on human malignant glioma cell line, U87MG; in vitro study.
Yoshida D; Hoshino S; Shimura T; Takahashi H; Teramoto A
J Neurooncol; 2000 Apr; 47(2):133-40. PubMed ID: 10982154
[TBL] [Abstract][Full Text] [Related]
9. Effects of estramustine and its constituents on human malignant glioma cells.
von Schoultz E; Lundgren E; Henriksson R
Anticancer Res; 1990; 10(3):693-6. PubMed ID: 2369085
[TBL] [Abstract][Full Text] [Related]
10. Effects of radiotherapy and estramustine on the microvasculature in malignant glioma.
Johansson M; Bergenheim AT; Widmark A; Henriksson R
Br J Cancer; 1999 Apr; 80(1-2):142-8. PubMed ID: 10389990
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by estramustine phosphate mediated by phosphorylation of bcl-2.
Yoshida D; Noha M; Watanabe K; Takahashi H; Sugisaki Y; Teramoto A
J Neurooncol; 2001 Aug; 54(1):23-9. PubMed ID: 11763419
[TBL] [Abstract][Full Text] [Related]
12. Imaging blood flow in brain tumors using arterial spin labeling.
Silva AC; Kim SG; Garwood M
Magn Reson Med; 2000 Aug; 44(2):169-73. PubMed ID: 10918313
[TBL] [Abstract][Full Text] [Related]
13. Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate.
Behnam-Motlagh P; Sandström PE; Henriksson R; Grankvist K
J Cancer Res Clin Oncol; 2002 Aug; 128(8):449-55. PubMed ID: 12200602
[TBL] [Abstract][Full Text] [Related]
14. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.
Bergenheim AT; Gunnarsson PO; Edman K; von Schoultz E; Hariz MI; Henriksson R
Br J Cancer; 1993 Feb; 67(2):358-61. PubMed ID: 8431366
[TBL] [Abstract][Full Text] [Related]
15. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.
Devineni D; Klein-Szanto A; Gallo JM
Cancer Res; 1996 May; 56(9):1983-7. PubMed ID: 8616836
[TBL] [Abstract][Full Text] [Related]
16. The bleb formation of the extracellular pseudopodia; early evidence of microtubule depolymerization by estramustine phosphate in glioma cell; in vitro study.
Yoshida D; Noha M; Watanabe K; Bergenheim T; Henriksson R; Teramoto A
J Neurooncol; 2001 Mar; 52(1):37-47. PubMed ID: 11451201
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.
Hori K; Saito S; Nihei Y; Suzuki M; Sato Y
Jpn J Cancer Res; 1999 Sep; 90(9):1026-38. PubMed ID: 10551334
[TBL] [Abstract][Full Text] [Related]
18. Targeting microtubule-associated proteins in glioblastoma: a new strategy for selective therapy.
Piepmeier JM; Pedersen PE; Yoshida D; Greer C
Ann Surg Oncol; 1996 Nov; 3(6):543-9. PubMed ID: 8915486
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of estramustine phosphate.
Bergenheim AT; Henriksson R
Clin Pharmacokinet; 1998 Feb; 34(2):163-72. PubMed ID: 9515186
[TBL] [Abstract][Full Text] [Related]
20. Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats.
Stuhr LE; Raa A; Oyan AM; Kalland KH; Sakariassen PO; Petersen K; Bjerkvig R; Reed RK
J Neurooncol; 2007 Nov; 85(2):191-202. PubMed ID: 17557137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
